Table: begin end state 1 6 cytoplasmic 7 45 transmembrane 46 48 non-cytoplasmic 49 57 cytoplasmic 58 79 transmembrane 80 98 non-cytoplasmic 99 125 transmembrane 126 140 cytoplasmic 141 168 transmembrane 169 178 non-cytoplasmic 179 200 transmembrane 201 220 cytoplasmic 221 242 transmembrane 243 247 non-cytoplasmic 248 267 transmembrane 268 274 cytoplasmic 275 300 transmembrane 301 316 non-cytoplasmic 317 336 transmembrane 337 340 cytoplasmic 341 362 transmembrane 363 367 non-cytoplasmic 368 393 transmembrane 394 410 cytoplasmic 411 434 transmembrane 435 439 non-cytoplasmic
Input: >WP_029134923.1 NCBI__GCF_000428045.1:WP_029134923.1 MSGIAIGALMFAVLLLLIALRISIGVAMLLVGMIGYVALSGWSPLISYLKTAAYWRFSTY DLSVVPLFLLMGQFASKAGLSRALFHTASVWMGHRRGGIAMAAIGGCAGFGAICGSSLAT AATIGQVALPELKRHGYSGSLATGALAAGGTLGILIPPSVILVIYAILTEGNIATMFQAA FIPGFLAAFGYLIAISVYVRLKPDSGPAGPATSWREKFSSLGDVWAVTTIFLVVIGGIYA GAFTPTEGAAVGAVSTGLLALIHGHLRWDGLRECLLGTASATGMIFLIVFGADVFNAFLA LTQMPAEAASMIGQSNLSPYLVLVVMLVLYLIFGCVMDSLSMILLTIPIFWPILMVLDFG MSPDDLKIWFGIIALIVVEVGLITPPVGMNVFIINKMAVNVPMIESFKGVLPFLISDIVR VVILILFPSITLLLPRLFS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server